As a company, we carry out our R&D studies in line with our strategies and aim to present the resulting products to national and international markets.While we are trying to develop products that will solve as many unmet needs as possible, we are also trying to produce quality diagnostic kits that can be an alternative to the existing diagnostic systems in the market in terms of speed and convenience. We group our products under four headings.
We offer in-vitro medical diagnostic kits to the market for both infectious diseases that are important for public health and different infectious diseases that concern individuals in clinics.
Our current brands in the market are;
Since it is known that detecting the possibility of some genetic diseases in children in advance at the parental level will prevent some diseases, we give priority to developing diagnostic tests in this direction. Apart from that, we are also planning R&D activities in the fields of maternal and child diseases, rare diseases, cancer genetics and pharmacogenetics.
Our current product in the market is;
The focus of our molecular diagnostic product development studies on cancer is epigenetic mechanisms. In particular, we carry out R&D of products based on the relationship between methylation changes on cancer suppressor genes and cancer development. These allow early diagnosis in patients with cancer screening or symptoms in the community.
Our current product in the market